A novel variant of RyR2 gene in a family misdiagnosed as congenital long QT syndrome: The importance of genetic testing
Authors:
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Electrocardiology
- Vol. 60, 8-11
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 ― Modified Schwartz Score ―Circulation Journal, 2018
- Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting GenesPLOS ONE, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testingBMC Cardiovascular Disorders, 2012
- The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT SyndromeJACC, 2009
- Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testingHeart Rhythm, 2005
- Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia SyndromesCirculation, 2004
- Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular TachycardiaCirculation, 2002